HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful treatment of newly diagnosed POEMS syndrome with reduced-dose bortezomib based regimen.

AuthorsHaiyan He, Weijun Fu, Juan Du, Hua Jiang, Jian Hou
JournalBritish journal of haematology (Br J Haematol) Vol. 181 Issue 1 Pg. 126-128 (04 2018) ISSN: 1365-2141 [Electronic] England
PMID28146276 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Bortezomib
Topics
  • Aged
  • Bortezomib (administration & dosage, adverse effects)
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • POEMS Syndrome (blood, diagnosis, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: